Twitter icon Email alerts icon Latest News RSS icon Magazine icon Stay connected:

View the article online at http://citywire.co.uk/wealth-manager/article/a758701

Overnight Markets: Wall Street declines on Iraq concerns

by Himanshu Singh on Jun 25, 2014 at 04:17

Overnight Markets: Wall Street declines on Iraq concerns

Wall Street declined on Tuesday as early enthusiasm from economic data was overshadowed by reports of escalating violence in the Middle East.

The Dow Jones industrial average declined 119 points or 0.7%, to end at 16,818. The S&P 500 lost 13 points or 0.64%, to 1,950. The Nasdaq Composite dropped 18 points or 0.42%, to 4,350.

Shares gained in early trading after data showed consumer confidence surged more than expected in June, while new home sales in May rose more than anticipated, boosting optimism in the world’s biggest economy.

In another snapshot of the housing sector, the S&P/Case-Shiller composite index showed single-family home prices rose less than expected in April.

However, the market's gains evaporated in the afternoon on concerns about an escalation of the conflict in Iraq. US Secretary of State John Kerry urged leaders of Iraq's autonomous Kurdish region on Tuesday to stand with Baghdad in the face of a Sunni insurgent onslaught that threatens to destroy the country.

Walgreen Co (WAG.N) shares declined 1.7% after the largest US drugstore chain reported its third-quarter results.

Exxon Mobil Corp. fell 1.6% and Pioneer Natural Resources Co. slumped 4.8% as energy shares led declines. Intercontinental Exchange Inc. fell 4% after an analyst downgraded the stock.

Elizabeth Arden Inc. fell 3.1% after the maker of Elizabeth Taylor and Britney Spears perfumes announced a restructuring programme that will eliminate jobs and shut its Puerto Rico affiliate.

Intercontinental Exchange fell 4% for the biggest drop since May after Wells Fargo Securities cut the rating on the second-largest operator of security exchanges to the equivalent of hold from the equivalent of buy.

Biotech shares were a bright spot, buoyed by a 40.4% surge in Vertex Pharmaceuticals Inc (VRTX.O) after the company said a combination of drugs designed to treat cystic fibrosis succeeded in improving lung function in a pair of closely watched late-stage clinical trials.

Sign in / register to view full article on one page

leave a comment

Please sign in here or register here to comment. It is free to register and only takes a minute or two.

News sponsored by:

Sponsored Video: Bringing it all back home


As the UK coalition government strives to rebalance the national economy, so called 'reshoring' looks set to play an increasingly important role in economic recovery.

Today's top headlines

Sponsored Video: Barings on investing in Frontier Markets


From Nigeria to Pakistan and from Kenya to Kuwait, frontier markets are catching investors' attention as never before.

More about this:

Archive

On the road

Click here to find out more from the Audience Development team.

Sorry, this link is not
quite ready yet